Piramal Enterprises is currently 5% of my Portfolio and is a Free Holding for me. So not interested in buying more.
However, I have to agree both Strides and Edelweiss have higher allocation currently and I will either bring down or completely exit my allocation at an appropriate time.
Please bear in mind that I have higher capacity to hold in terms of time period and capacity to suffer. Currently both Strides & Edelweiss are loss making in my PF.
If I absolutely have to, sell the ones whose management you trust the least.
As per my research, holding company discounts remain for good reason (non-current liabilities) and they are here to stay. So i don’t invest in those however cheap they might appear. I think I shared the same view earlier also in your thread. Apologize for repitition.
Since January 2022, I felt better opportunities exist else where and have totally exited
Edelweiss, Godrej Consumer, Hikal, Solara and Strides
Have added Deepak Nitrite, Jubilant Foodworks and Dhampur Sugar.
Increased my allocations in HDFC Life, Asian Paints, Pidilite, P I Industries, Neuland and Sequent.
Sold out few underperformers and moved to better opportunities. Ideally I would have liked to bring down the number of stocks but I wanted to strictly keep all stocks below 10% allocation and sectoral allocations below 30% for better diversification.
I have now exited
Asian Paints - Due to expensive valuations and I expect it to come down further due to new entrants HDFC Life - Due to better opportunities in market and at better valuations
Narayana Hrudayalaya - I feel better opportunities are available in market
Added Balaji Amines and Praj Industries.
Increased allocations in Indoco, Suven, Laurus.
Have been accumulating Piramal Pharma continuously, already have decent Qty after demerger from PEL.
While I have slightly increased allocations to Balaji Amines and Praj Industries.
I have now offloaded Piramal Enterprises (PEL) and will soon get rid of Indoco, Suven Pharma and ICICI Lombard to have more cash in hand as I await better opportunities in the market in the near future.
Not necessarily new ideas but might also increase stakes in existing holdings.